Veniron Injection 100 mg/5 ml contains Iron Sucrose, a parenteral iron preparation used for the treatment of iron deficiency anemia when oral iron therapy is ineffective, not tolerated, or contraindicated. It is especially beneficial in patients with chronic kidney disease, those undergoing hemodialysis, and patients who require rapid replenishment of iron stores. Veniron Injection provides a reliable and efficient method of restoring iron levels, supporting hemoglobin synthesis and improving overall hematologic status.
Iron deficiency anemia is a common condition characterized by reduced hemoglobin levels due to insufficient iron, leading to symptoms such as fatigue, weakness, shortness of breath, and reduced exercise tolerance. Veniron Injection delivers iron directly into the bloodstream, bypassing gastrointestinal absorption issues and ensuring effective utilization by the body.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Veniron Injection is indicated for:
Treatment of iron deficiency anemia
Iron deficiency in patients with chronic kidney disease
Patients receiving hemodialysis or peritoneal dialysis
Patients who cannot tolerate or adequately absorb oral iron preparations
Situations where rapid iron replacement is clinically required
Hematinic
Parenteral iron preparation
Iron Sucrose is a stable iron-carbohydrate complex that releases iron slowly to iron-binding proteins such as transferrin. Once administered intravenously, iron sucrose dissociates into iron and sucrose. The iron component is taken up by the reticuloendothelial system and subsequently made available for hemoglobin synthesis in the bone marrow. This controlled release minimizes the risk of free iron toxicity while ensuring efficient correction of iron deficiency.
Compared to older parenteral iron formulations, iron sucrose is associated with a lower incidence of severe hypersensitivity reactions and is generally well tolerated when administered according to recommended guidelines.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
The dosage is determined based on the patient’s hemoglobin level, body weight, and total iron deficit
Usually administered by slow intravenous injection or intravenous infusion
The typical dose is 100 mg (5 ml) per administration
Frequency and total cumulative dose should be decided by a healthcare professional
Veniron Injection should be administered in a clinical setting under medical supervision
Oral iron therapy should be avoided during parenteral iron treatment as it may interfere with iron absorption
Caution is advised when used with other medications that may affect hematologic parameters
No significant drug interactions are commonly reported when used appropriately
Known hypersensitivity to iron sucrose or any component of the formulation
Anemia not caused by iron deficiency
Iron overload disorders such as hemochromatosis
Acute or chronic infections where iron administration may be contraindicated
Common side effects may include nausea, vomiting, dizziness, headache, hypotension, and injection site reactions. Some patients may experience flushing, muscle cramps, or taste disturbances. Rarely, hypersensitivity reactions such as rash, pruritus, or bronchospasm may occur. Severe anaphylactic reactions are uncommon but require immediate medical attention.
Veniron Injection should only be administered by trained healthcare professionals
Patients should be monitored during and after administration for signs of hypersensitivity
Use with caution in patients with liver disease or active infection
Resuscitation facilities should be readily available during administration
Pregnancy: Use only if clearly needed and prescribed by a physician
Lactation: Iron sucrose is considered compatible with breastfeeding under medical supervision
Pediatric use: Safety and efficacy should be determined by a specialist
Store below 30°C
Protect from light
Do not freeze
Keep out of reach of children
Login Or Registerto submit your questions to seller
No none asked to seller yet